Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis
- PMID: 20056222
- PMCID: PMC2884178
- DOI: 10.1016/j.atherosclerosis.2009.11.047
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis
Abstract
Macrophage presence within atherosclerotic plaque is a feature of instability and a risk factor for plaque rupture and clinical events. Activated macrophages express high levels of the translocator protein/peripheral benzodiazepine receptor (TSPO/PBR). In this study, we investigated the potential for quantifying plaque inflammation by targeting this receptor. TSPO expression and distribution in the plaque were quantified using radioligand binding assays and autoradiography. We show that cultured human macrophages expressed 20 times more TSPO than cultured human vascular smooth muscle cells (VSMCs), the other abundant cell type in plaque. The TSPO ligands [3H](R)-1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3-isoquinoline carboxamide ([3H](R)-PK11195) and [3H]N-(2,5-dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide ([3H]-DAA1106) bound to the same sites in human carotid atherosclerotic plaques in vitro, and demonstrated significant correlation with macrophage-rich regions. In conclusion, our data indicate that radioisotope-labelled DAA1106 has the potential to quantify the macrophage content of atherosclerotic plaque.
Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
Figures
References
-
- Fuster V., Stein B., Ambrose J.A. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation. 1990;82:II47–II59. - PubMed
-
- Libby P., Geng Y.J., Aikawa M. Macrophages and atherosclerotic plaque instability. Curr Opin Lipidol. 1996;7:330–335. - PubMed
-
- Rudd J.H., Myers K.S., Bansilal S. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871–878. - PubMed
-
- Tawakol A., Migrino R.Q., Bashian G.G. In vivo 18F-flurodeoxyglucose positron emission tomography imaging provides a non-invasive measure of carotid plaque inflammation in patients. J Am Acad Cardiol. 2006;48:1818–1824. - PubMed
-
- Rudd J.H.F., Warburton E.A., Fryer T.D. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708–2711. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
